Century Therapeutics, Inc. (IPSC) Operating margin 2022–2025
Century Therapeutics, Inc. (IPSC) operating margin by fiscal year — reported operating income divided by reported revenue.
-15.8%FY2025 · since FY2022: -2574.2% → -15.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15.8% | +2080.7 pp |
| FY2024 | -2096.5% | +4460.4 pp |
| FY2023 | -6556.9% | -3982.7 pp |
| FY2022 | -2574.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating cash flowIPSC Free cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →